Companies in #Antiviral
Found 3 companies operating in this sector.
Ascletis Pharma is a China-based clinical-stage biopharmaceutical company developing small-molecule and peptide therapeutics for viral diseases, metabolic diseases (including obesity), and oncology. Its lead metabolic candidate ASC36_35 FDC targets GLP-1/GIP agonism.
AusperBio
PrivateClinical-stage biopharmaceutical company focused on developing novel therapeutics for chronic hepatitis B virus (HBV) infection. Raised $120M Series C to advance its lead HBV drug candidate through Phase 3 clinical trials.
EIT Pharma
PrivateBiopharmaceutical company developing lonafarnib for chronic hepatitis delta (HDV), a serious liver infection. NDA accepted by FDA in 2026.